• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

MUCORMYCOSIS DURING THE SECOND WAVE OF COVID19 PANDEMIC IN SOUTH RAJASTHAN: AN ANALYTICAL CROSS SECTIONAL STUDY

    Dr. Sandhya Mishra, Dr. Anshu Sharma, Dr. Seema Sonkariya, Dr. Sarika Sarawat

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 1872-1884

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Mucormycosis is an opportunistic infection caused by several fungi belonging
to phylum Glomeromycota. They are found ubiquitously in the soil and
environment.
They are classified under subphylum Mucoromycotina and
Entomopthoromycotina. Mucormycosis caused by members belonging to
subphylum Mucoromycotina, order Mucorales, is the most clinically important
and includes the genera Lichtheimia, Mucor, Rhizomucor and Rhizopus species.
It is a very rapidly progressive (because of its angioinvasive nature) thereby
may prove fatal if timely diagnosis is not made entailing delay in institution of
specific treatment. It presents as six clinical types Rhino-orbito-cerebral,
Pulmonary, Cutaneous, Gastrointestinal, Isolated Renal and Disseminated
Mucormycosis on the basis of anatomical site involved in a particular patient.
Keywords:
  • PDF (641 K)
  • XML
(2022). MUCORMYCOSIS DURING THE SECOND WAVE OF COVID19 PANDEMIC IN SOUTH RAJASTHAN: AN ANALYTICAL CROSS SECTIONAL STUDY. European Journal of Molecular & Clinical Medicine, 9(4), 1872-1884.
Dr. Sandhya Mishra, Dr. Anshu Sharma, Dr. Seema Sonkariya, Dr. Sarika Sarawat. "MUCORMYCOSIS DURING THE SECOND WAVE OF COVID19 PANDEMIC IN SOUTH RAJASTHAN: AN ANALYTICAL CROSS SECTIONAL STUDY". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 1872-1884.
(2022). 'MUCORMYCOSIS DURING THE SECOND WAVE OF COVID19 PANDEMIC IN SOUTH RAJASTHAN: AN ANALYTICAL CROSS SECTIONAL STUDY', European Journal of Molecular & Clinical Medicine, 9(4), pp. 1872-1884.
MUCORMYCOSIS DURING THE SECOND WAVE OF COVID19 PANDEMIC IN SOUTH RAJASTHAN: AN ANALYTICAL CROSS SECTIONAL STUDY. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 1872-1884.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 37
  • PDF Download: 50
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus